A new study on mice published in Nature Neuroscience finds that fingolimod (Novartis brand name Gilenya) a first-in-class sphingosine-1-phosphate-receptor modulator currently used in treating persons with severe relapsing remitting MS, may also have therapeutic value in treating Post Traumatic Stress Disorder (PTSD). The Nature Neuroscience study is titled…
Gilenya
Recommended Posts
- Pilates, resistance training exercises may protect nerves in MS
- How these famous ‘Aliens’ quotes apply to life with MS
- What MS patients eat may shape their disability scores in 1 year
- Mild brain stimulation therapy helps MS patients’ walking, balance
- Pilates improves mobility and balance, fatigue in MS: Review study